The year-end sprint for Hong Kong stock IPOs has come to an end, with 6 companies listing on the same day!

The annual IPO battle for Hong Kong stocks has begun, with six companies simultaneously launching IPOs and finalizing a unified listing date. According to an announcement from the Hong Kong Stock Exchange, Yingsi Smart (03696. HK), Wuyi Vision (06651. HK), Xunzi (03317. HK), Meilian Shares (02671. HK), Wo'an Robotics (06600. HK), and Lin Qingxuan (02657. HK) will launch intensive IPOs at the end of the year, and are all scheduled to collectively enter the Hong Kong stock market on December 30th, staging the "finale" of their annual IPOs.

The lineup for this sprint covers a variety of popular tracks, with representative companies from fields such as AI pharmaceuticals, digital twins, home robots, and high-end skincare making appearances. Among them, technology content companies occupy half of the market, becoming the core focus of this IPO wave. A reporter from the Science and Technology Innovation Board Daily found that the industry distribution of six companies accurately corresponds to the structural characteristics of Hong Kong stock IPOs throughout the year - technology and new consumption have become the main financing drivers.

Huang Lichong, President of Huisheng International Capital, stated in an interview that the year-end intensive IPO is a common "sprint closing" phenomenon in strong years for Hong Kong stocks, driven jointly by enterprises and investment banks. This trend not only confirms the financing heat of the Hong Kong stock market this year, but also highlights the urgent need for high-quality enterprises to seize the year-end market window to complete their listing. He further pointed out that the industry composition of the six companies this time precisely reflects the core pattern of the IPO market throughout the year, which is "technology oriented and diversified supplementation".

From the perspective of specific enterprises, the fundraising scale and market attention of technology targets are both high. Yingsi Intelligence, known as the "AI pharmaceutical pioneer", has built more than 30 innovative drug pipelines covering popular fields such as cancer and metabolism through its self-developed Pharma.AI platform. The pricing is HKD 24.05 per share, and it is expected to raise HKD 2.277 billion, ranking first among the six companies in terms of fundraising scale.

Focusing on the May Day vision of digital twins and physical AI technology, it has attracted much attention as the annual closing project of the Hong Kong Stock Exchange's 18C Special Technology Channel. The company will issue 23.975 million shares globally at a price of HKD 30.5 per share, with an expected fundraising of HKD 731 million. If the over allotment option is exercised, the maximum fundraising amount can reach HKD 841 million; The appearance of well-known entities such as Moore Thread and Ge Weidong in its shareholder list has further increased market attention.

Instant data infrastructure service provider Xunzi stands out with its industry position and cornerstone lineup. According to the data, based on the revenue in 2024, Xunzie ranks first in the real-time data service market of the domestic asset management industry with a share of 11.6%; The pricing range for this IPO is 48-55 Hong Kong dollars, with an expected fundraising of 1.08-1.23 billion Hong Kong dollars. At the same time, 9 cornerstone investors including Zhongshi Jinqiao and Alphahil Fund have been introduced, with a total subscription of approximately 308 million Hong Kong dollars, laying a solid foundation for the stability of the issuance.

In addition, Wo'an Robotics, with the shareholder background of "DJI Godfather" Li Zexiang, focuses on the embodied home robot track and is jointly sponsored by Guotai Junan International and Huatai International. After completing the hearing, it quickly joined the year-end IPO queue; Lin Qingxuan in the new consumer sector globally issued 13.96645 million shares at a price of HKD 77.77 per share, with CITIC Securities and Huatai International serving as joint sponsors.

Meilian Corporation, in the traditional industrial sector, has taken a differentiated approach. As a steel structure construction service provider, the company's listing plan reflects the financing demands of traditional industry transformation enterprises, which is highly in line with the structure of the Hong Kong IPO market, which is "technology oriented and diversified supplemented".

The year-end new stock wave presents both opportunities and challenges for investors. According to historical data, among the new stocks listed on the Hong Kong stock market in 2025, 21 (including 8 18A biotechnology companies) have accumulated gains of over 100%, but at the same time, nearly 30% of the new stocks have experienced IPOs. Regarding this, Huang Lichong reminds investors to focus on three core dimensions: the core technological barriers and commercialization progress of technology enterprises, the brand power and profit stability of consumer enterprises, and the transformation effectiveness and cash flow status of traditional enterprises.